Week in Review: The Latest from PhRMA

Priscilla VanderVeer   |     August 21, 2015   |   SHARE THIS

week-in-reviewThe Value of Biopharmaceutical Innovation:  The continued development of new treatments and cures not only contributes valuable knowledge to the research and development process, it also improves patients’ lives, advances medical innovation, makes health care better and fuels economic growth. Learn more about the impact of biopharmaceutical innovation here.

Q&A with RxEconomics LLC: In the latest Ask About Adherence series, we feature a Q&A with RxEconomics President and CEO M. Christopher Roebuck  about medication adherence and economic evaluation of prescription drugs.

The Clinical Pathways Debate: In this guest blog, Alan Balch, the CEO of the National Patient Advocate Foundation, tells us about clinical pathways and what they mean for patients and their treatment options .

The Case for Sharing Truthful, Non-Misleading Information: Earlier this week, The Wall Street Journal editorialized on the importance of free speech in the context of sharing scientific and medical information. The editorial calls on the U.S. Food and Drug Administration to update its regulatory framework for biopharmaceutical communications with health care professionals so that physicians can make informed prescribing decisions. Find out more here.

Medicare Monday: Check out this week’s post, which busts a popular myth about negotiation in Medicare Part D, explaining how powerful Part D purchasers negotiate discounts and rebates directly with manufacturers that save money for both beneficiaries and taxpayers.

Priscilla VanderVeer

Priscilla VanderVeer Priscilla VanderVeer Priscilla VanderVeer is a vice president, public affairs, at PhRMA. Ms. VanderVeer has more than 15 years of experience communicating important health care issues to a wide variety of audiences, including medical, health and patient advocates; policymakers and opinion-leaders; and the general public. At PhRMA, Ms. VanderVeer leads the development and execution of communications strategies and activities for the organization’s key state advocacy priorities. She lives in Annapolis, Maryland with her husband, Ken and their two dogs: Bea Arthur, a tiny 5 lb. Maltese and Henry, a slightly larger-than-average Yorkshire Terrier.

Topics: Adherence

Search the Catalyst

View Posts by Topic

see all

View Posts by Date

see all

Subscribe to Email Updates